Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$22.4K Hold
200
0.01% 121
2024
Q2
$24.8K Sell
200
-312
-61% -$40.2K 0.01% 116
2024
Q1
$66.5K Sell
512
-76
-13% -$9.37K 0.02% 84
2023
Q4
$67.5K Buy
+588
New +$61K 0.02% 82
2022
Q3
Sell
-94
Closed -$8.57K 274
2022
Q2
$8.57K Buy
+94
New +$8.33K ﹤0.01% 172
2022
Q1
Sell
-150
Closed -$11.5K 255
2021
Q4
$11.5K Buy
150
+50
+50% +$3.98K ﹤0.01% 178
2021
Q3
$7.51K Hold
100
﹤0.01% 197
2021
Q2
$7.78K Sell
100
-5
-5% -$372 ﹤0.01% 156
2021
Q1
$7.71K Buy
+105
New +$7.75K ﹤0.01% 158

Other funds holding MRK

Halpern Financial's MRK Position: Q3 2024 in Review

Halpern Financial held its Merck (MRK) position steady in Q3 2024 at 200 shares worth $22.4K. The position accounts for 0.01% of the portfolio, ranked #121.

Halpern Financial first reported a position in MRK in Q1 2021 and has held it in 9 quarters since. The position peaked at $67.5K in Q4 2023. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Halpern Financial held 200 shares of Merck worth $22.4K as of Q3 2024.
  • Halpern Financial left its Merck share count unchanged in Q3 2024.
  • Merck made up 0.01% of Halpern Financial's portfolio in Q3 2024, its #121 holding.
  • Halpern Financial first reported a position in Merck in Q1 2021 and has held it in 9 quarters since.
  • Halpern Financial's Merck position peaked at $67.5K in Q4 2023.
  • 3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Halpern Financial's 13F filing for Q3 2024, filed 4 Oct 2024.